Panel Discussion

Saturday, March 8, 2025

9:25 AM – 10:05 AM ET

Panel Moderator(s)

Mark R. Hofmeyer, MD, FACC

Attending Physician - Advanced Heart Failure Associate Professor - Georgetown University School of Medicine
MedStar Health
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Mandeep R. Mehra, MD, MSc, FRCP

William Harvey Chair in Cardiovascular Medicine
Brigham and Women's Hospital
Needham, Minnesota, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); Cadrenal: Consultant (Ongoing); Fineheart: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); FIRE-1: Consultant (Ongoing); leviticus: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Moderna: Consultant (Ongoing); NupulseCV: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Paragonix Therapeutics, Inc.: Consultant (Ongoing); TransMedics (Organ Transplant ) TMDX : NASDQ: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Ileana L. Pina, MD, MPH

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

Disclosure(s): BOEHRINGER INGELHEIM IT.SpA.: advisory Board (Ongoing)

Panel Discussant(s)

Jacob Abraham, MD

Section Head, Advanced Heart Failure
Providence heart Institute
Portland, Oregon, United States

Disclosure(s): Abbott: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed Inc: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Adona: Consultant (Ongoing); Ancora: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CVRx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock-privately held company (Ongoing); Edwards Lifesciences: Consultant (Ongoing)
Jennifer R. Brown, MD

Director of Heart Failure Services in Annapolis, MD
MedStar Health

Disclosure(s): No financial relationships to disclose
Jonathan Grinstein, MD

Advanced Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation Physician
University of Chicago
MedStar Washington Hospital Center
Bethesda, MD, United States

Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BrioHealth: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PAC Dynamic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), This is a startup. I am the founder (Ongoing); Restore Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Data Safety Monitoring Board (Ongoing)
RK

Rania Kaoukis, MD

Advanced Heart Failure Cardiologist
MedStar Health

Disclosure(s): No financial relationships to disclose
PL

Phillip H. Lam, MD

Advanced Heart Failure Cardiologist
MedStar Health

Disclosure(s): No financial relationships to disclose
KAVITA SHARMA, MD

Director of Heart Failure and Cardiac Transplantation
Johns Hopkins University School of Medicine
Ellicott City, Maryland, United States

Disclosure(s): Alleviant: Consultant (Ongoing); Amgen Inc: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bayer: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Cytokinetics: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); Novo Nordisk: Consultant (Ongoing); Rivus: Consultant (Ongoing)

Disclosure(s):

Mark R. Hofmeyer, MD, FACC: No financial relationships to disclose

Mandeep R. Mehra, MD, MSc, FRCP: Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); Cadrenal: Consultant (Ongoing); Fineheart: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); FIRE-1: Consultant (Ongoing); leviticus: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Moderna: Consultant (Ongoing); NupulseCV: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Paragonix Therapeutics, Inc.: Consultant (Ongoing); TransMedics (Organ Transplant ) TMDX : NASDQ: Consultant (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Ileana L. Pina, MD, MPH: BOEHRINGER INGELHEIM IT.SpA.: advisory Board (Ongoing)

Jacob Abraham, MD: Abbott: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed Inc: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Adona: Consultant (Ongoing); Ancora: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CVRx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock-privately held company (Ongoing); Edwards Lifesciences: Consultant (Ongoing)

Jennifer R. Brown, MD: No financial relationships to disclose

Jonathan Grinstein, MD: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BrioHealth: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PAC Dynamic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), This is a startup. I am the founder (Ongoing); Restore Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Data Safety Monitoring Board (Ongoing)

Rania Kaoukis, MD: No financial relationships to disclose

Phillip H. Lam, MD: No financial relationships to disclose

KAVITA SHARMA, MD: Alleviant: Consultant (Ongoing); Amgen Inc: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bayer: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Cytokinetics: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); Novo Nordisk: Consultant (Ongoing); Rivus: Consultant (Ongoing)